China Southern Airlines (600029.sh) announced that qatar airways shareholder Qatar Airways purchased 8,600 shares of the company's a-shares through the centralized trading system of the Shanghai-Hong Kong Stock Exchange on December 28, 2018, and purchased 6,000 shares of the company's h-shares through the centralized trading system of the Hong Kong Stock Exchange. After the change of interests, Qatar Airways holds a total of 5% of the company's shares. Qatar Airways may consider further increasing its stake in the company over the next 12 months.
Comments: Qatar Airways' overweight behavior occurred in November and December 2018, from no direct increase to raising the card, which is very efficient. Qatar Airways said the acquisition is part of its strategic investment to continue to enhance its operational capabilities and aviation connectivity. Qatar Airways and American Airlines, which has close ties to China Southern Airlines, are part of the world. OneWorld is also the most likely alliance place expected by the market after China Southern Airlines withdraws from SkyTeam.
【Daye Special Steel: Proposed 23.2 billion yuan to purchase 86.5% equity of Xingcheng Special Steel】 Daye Special Steel (000708.sz) announced that it intends to pay consideration of 23.2 billion yuan with shares to purchase 86.5% of the equity of Xingcheng Special Steel, and the company's shares will resume trading from the opening of the market on the morning of January 3, 2019.
Comments: The high-standard bearing steel and automotive steel produced by Xingcheng Special Steel, which are loaded into the listed company, have ranked first in the country for several consecutive years and have a stable market position. After the completion of this transaction, the assets of CITIC Group's special steel sector will be listed as a whole in A shares, and the production capacity of listed companies' special steel will reach 13 million tons, becoming the world's largest special steel production enterprise, which can be actively concerned.
[Palm Shares: Plans to invest 6.6 billion yuan to build Hainan Characteristic Town] Palm Shares (002431.sz) announced that its holding subsidiary, Hainan Palm Ecological Town Development Co., Ltd., recently signed the "Haiken Palm Wanquan River Characteristic Town Project Cooperation Contract" with Hainan Nongken Dongtai Farm Co., Ltd., with a total investment of 6.6 billion yuan.
Comments: Being able to deeply participate in the construction of the Hainan Free Trade Zone is a good thing for the company. The project amount is relatively high, but the construction period is up to 10 years, which has a good impact on performance, but the impact will not be reflected soon.
[Yonyou Network: Proposed 1 billion yuan to repurchase shares] Yonyou Network (600588.sh) announced that it intends to repurchase the company's shares in a centralized auction transaction, with a total repurchase fund of 1 billion yuan and a repurchase price of no more than 26 yuan per share.
Comments: Yonyou Network in the first three quarters of 2018 performance is good, to achieve net profit increased by 158% year-on-year, the company's stock price since September 5 last year fell by up to 28%, according to the repurchase price ceiling of 26 yuan / share calculation, Yonyou Network intends to repurchase shares accounted for about 2% of the company's current total share capital, as of January 2, its latest closing price is 21.8 yuan / share, from the upper limit of the repurchase price has a large room for growth.
【Xinjiang Torch: Shareholders intend to reduce their total holdings of not more than 26.28% of the shares】 Xinjiang Torch (603080.sh) announced that Jiuding Investment, a shareholder holding a total of 17.19% of the shares, intends to reduce its holdings by a total of no more than 24.32 million shares, that is, not more than 17.19% of the company's total share capital; shareholders Junan Xianghe and Wang Anliang, who hold a total of 9.09% of the shares, intend to reduce their holdings by a total of no more than 12.86 million shares, that is, not more than 9.09% of the company's total share capital.
Comments: This reduction is just after the listing and circulation of Xinjiang Torch initial public offering restricted shares. The market's negative perception of Xinjiang Torch has been reflected in the stock price, and the company's stock price has fallen sharply in the past three trading days.
【CHINA RESOURCES SANJIU: The listed transaction price of the equity of Sanjiu Hospital is 926 million yuan】 China Resources Sanjiu (000999.sz) announced that it intends to determine Shenzhen Xinshen Hospital Management Co., Ltd. as the transferee of Sanjiu Hospital, and determine that the turnover of its 100% equity is 1.117 billion yuan, and the corresponding turnover of the 82.89% equity held by the company is 926 million yuan. The sale is expected to generate approximately $680 million (after-tax) proceeds from the disposal of assets for the Company.
Comments: The company is mainly engaged in OTC and Chinese medicine prescription drugs, the transfer of Sanjiu Hospital has been in preparation since 1994, the company has become the controlling shareholder since 2009, but the hospital is still under construction and can not start formal business, the company's divestiture will reduce the burden. The valuation of the target is nearly 29% premium to the company's initial offer, and the company will gain more benefits as a result, which will have a positive impact on short-term performance.
【Hokuriku Pharmaceutical: 2018 annual net profit pre-increase 10%-35%】 Hokuriku Pharmaceutical (300016.sz) released a performance forecast, and it is expected that the net profit in 2018 will be 131 million yuan - 160 million yuan, an increase of 10% -35% year-on-year; revenue will be 575 million yuan - 679 million yuan, an increase of 10% - 30% year-on-year.
Comments: It is not easy for the company to continue to maintain growth on the basis of a year-on-year increase of 6 times in net profit in 2017 last year, which is largely due to the company's increase in the marketing and bidding of the ratio products iodixanol injection and iopasol injection, and continuously improve the industrial chain through acquisitions, and promote the steady growth of the revenue of the contrast agent series products. However, the contribution of this sector to the company's performance has remained at about 90% all year round, showing that the single risk problem of the company's products is still difficult to solve.
[Stellar Technology: Plans to invest in the construction of a high-performance silicone polymer project with an annual output of 120,000 tons] Stellar Technology (002132.sz) announced on January 2 that Stellar Chemical, a wholly-owned subsidiary of the company, intends to invest in the construction of "Inner Mongolia Stellar Chemical Co., Ltd. annual output of 120,000 tons of high-performance silicone polymer project", with an estimated total investment of 2.1 billion yuan, of which fixed asset investment is 2 billion yuan and working capital is 90.69 million yuan. After the completion of the project, it is expected that the average annual sales will be 2 billion yuan, and the investment profit margin will be 20%.
Comments: Based on the estimated profit margin, it can be deduced that the annual EBIT of the project is 427 million yuan. In 2017, the net profit of Stellar Technology was 56.59 million yuan, and the net loss in the first half of 2018 was 17.59 million yuan, so the commissioning of the project can greatly improve the performance of Stellar Technology.
